TRCT
DDS icon

Tower Research Capital (TRC)’s Dillards DDS Stock Holding History

Tower Research Capital (TRC)’s Portfolio DDS Stock Details DDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
254
+250
+6,250% +$156K ﹤0.01% 1878
2025
Q4 		$2.42K Sell
4
-183
-98% -$115K ﹤0.01% 4530
2025
Q3 		$115K Buy
187
+17
+10% +$8.79K ﹤0.01% 1887
2025
Q2 		$71K Buy
170
+85
+100% +$31.7K ﹤0.01% 2670
2025
Q1 		$30.4K Sell
85
-1,032
-92% -$444K ﹤0.01% 2599
2024
Q4 		$482K Sell
1,117
-1,520
-58% -$623K 0.01% 1087
2024
Q3 		$1.01M Buy
2,637
+1,754
+199% +$669K 0.03% 527
2024
Q2 		$389K Sell
883
-324
-27% -$140K 0.01% 1544
2024
Q1 		$569K Buy
1,207
+594
+97% +$243K 0.01% 791
2023
Q4 		$247K Sell
613
-455
-43% -$154K ﹤0.01% 1921
2023
Q3 		$353K Sell
1,068
-1,848
-63% -$610K 0.01% 1082
2023
Q2 		$951K Sell
2,916
-14
-0.5% -$4.28K 0.03% 539
2023
Q1 		$901K Buy
2,930
+2,699
+1,168% +$959K 0.03% 508
2022
Q4 		$75K Sell
231
-4,157
-95% -$1.35M ﹤0.01% 2044
2022
Q3 		$1.2M Buy
4,388
+2,098
+92% +$555K 0.02% 625
2022
Q2 		$505K Buy
2,290
+521
+29% +$150K 0.01% 1129
2022
Q1 		$474K Buy
1,769
+1,518
+605% +$392K ﹤0.01% 1182
2021
Q4 		$62K Sell
251
-828
-77% -$218K ﹤0.01% 2593
2021
Q3 		$186K Sell
1,079
-129
-11% -$24.5K ﹤0.01% 1887
2021
Q2 		$218K Buy
1,208
+41
+4% +$5.29K 0.01% 1849
2021
Q1 		$113K Sell
1,167
-5,636
-83% -$458K ﹤0.01% 2499
2020
Q4 		$429K Sell
6,803
-6,340
-48% -$310K 0.01% 1107
2020
Q3 		$480K Buy
13,143
+6,255
+91% +$176K 0.01% 1721
2020
Q2 		$178K Buy
6,888
+5,741
+501% +$162K 0.01% 1890
2020
Q1 		$42K Buy
1,147
+1,093
+2,024% +$63.9K ﹤0.01% 1368
2019
Q4 		$4K Sell
54
-563
-91% -$39.9K ﹤0.01% 2764
2019
Q3 		$41K Buy
617
+261
+73% +$16.7K ﹤0.01% 1935
2019
Q2 		$22K Buy
+356
New +$22.9K ﹤0.01% 2112
2019
Q1 		– Sell
-149
Closed -$9K – 3870
2018
Q4 		$9K Sell
149
-2,361
-94% -$162K ﹤0.01% 2528
2018
Q3 		$192K Buy
2,510
+1,175
+88% +$95.3K 0.01% 1002
2018
Q2 		$126K Buy
1,335
+545
+69% +$44.4K 0.01% 1294
2018
Q1 		$63K Buy
+790
New +$57K 0.01% 1547
2017
Q4 		– Sell
-1,890
Closed -$105K – 3606
2017
Q3 		$106K Buy
1,890
+1,877
+14,438% +$116K 0.01% 1296
2017
Q2 		$1K Sell
13
-624
-98% -$33K ﹤0.01% 2471
2017
Q1 		$34K Sell
637
-2,457
-79% -$135K ﹤0.01% 944
2016
Q4 		$194K Buy
3,094
+1,816
+142% +$119K 0.02% 644
2016
Q3 		$81K Buy
1,278
+1,178
+1,178% +$73.6K 0.01% 901
2016
Q2 		$6K Sell
100
-784
-89% -$51.2K ﹤0.01% 3253
2016
Q1 		$75K Buy
884
+844
+2,110% +$63.2K 0.01% 585
2015
Q4 		$3K Sell
40
-380
-90% -$30.6K ﹤0.01% 3412
2015
Q3 		$37K Sell
420
-535
-56% -$51.7K ﹤0.01% 1234
2015
Q2 		$100K Sell
955
-51
-5% -$6.26K 0.01% 818
2015
Q1 		$138K Buy
1,006
+656
+187% +$81.8K 0.02% 641
2014
Q4 		$44K Sell
350
-1,033
-75% -$115K ﹤0.01% 1096
2014
Q3 		$151K Buy
1,383
+763
+123% +$88.7K 0.02% 653
2014
Q2 		$72K Buy
620
+533
+613% +$55.6K 0.01% 1071
2014
Q1 		$8K Sell
87
-438
-83% -$39.6K ﹤0.01% 2808
2013
Q4 		$51K Sell
525
-2,042
-80% -$177K 0.01% 1372
2013
Q3 		$201K Buy
2,567
+1,260
+96% +$102K 0.02% 745
2013
Q2 		$107K Buy
+1,307
New +$111K 0.01% 474

Other funds holding DDS

Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tower Research Capital (TRC)'s DDS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Dillards (DDS) stake by 6,250% in Q1 2026, buying an estimated $156K and bringing the position to 254 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Tower Research Capital (TRC) first reported a position in DDS in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.2M in Q3 2022. 316 funds tracked by Wall St. Rank hold DDS as of Q1 2026.

  • Tower Research Capital (TRC) held 254 shares of Dillards worth $145K as of Q1 2026.
  • Tower Research Capital (TRC) bought 250 Dillards shares in Q1 2026, an estimated $156K.
  • Dillards made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1878 holding.
  • Tower Research Capital (TRC) first reported a position in Dillards in Q2 2013 and has held it in 50 quarters since.
  • Tower Research Capital (TRC)'s Dillards position peaked at $1.2M in Q3 2022.
  • 316 funds tracked by Wall St. Rank held Dillards as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.